Amgen announces European approval of Prolia Amgen Inc.

Amgen announces European approval of Prolia Amgen Inc. Prolia offers been approved in every 27 European Union member Norway plus claims, Liechtenstein and Iceland. The European acceptance of Prolia marks the 1st approval of the merchandise worldwide http://levitrainorge.com . ‘The European approval of Prolia is normally a substantial medical advance for patients with bone loss conditions,’ stated Will Dere, senior vice president and worldwide chief medical officer at Amgen. ‘Specifically, we believe that Prolia will offer sufferers with postmenopausal osteoporosis at improved risk for fracture an important alternative to current remedies.